Is Viking Therapeutics Stock Going to $50? Here's What the Bulls and Bears Are SayingThe Motley Fool • 07/04/26
Novo Nordisk vs. Viking: Which Obesity Drug Stock Is the Better Buy?Zacks Investment Research • 06/29/26
Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 06/26/26
VKTX Stock Jumps on Phase I Study Initiation for New Obesity DrugZacks Investment Research • 06/25/26
Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy AdultsPRNewsWire • 06/24/26
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo NordiskThe Motley Fool • 06/23/26
Viking Therapeutics, Inc. (VKTX) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/04/26
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn'tThe Motley Fool • 06/03/26
Viking Therapeutics' Q3 Catalyst That Could Turn Eli Lilly's and Novo Nordisk's Daily Weight Loss Pill Strategy Upside DownThe Motley Fool • 06/02/26
Why Is Viking Therapeutics (VKTX) Up 3.2% Since Last Earnings Report?Zacks Investment Research • 05/29/26